RGILDGilead Sciences Tokenized Stock (Reality)
Stock 24/7/365Issued by Reality
Gilead Sciences engages in the research, development, and commercialized production of biopharmaceutical prescription drugs. The R&D pipeline is highly concentrated on antiviral medications, specifically targeted treatment regimens for HIV and various viral hepatitides; it also ventures into the development of oncology cell therapies and inflammatory disease drugs. The company advances clinical reviews of compounds, primarily supplying approved medications in bulk to pharmacy networks, hospitals, and medical procurement agencies.
- Macro context: RGILD is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.
Data as of Nov 1, 2026
Price performance
7D
+8.32%
14D
+11.84%
30D
—
1Y
—
All-time
+17.97%
Key facts
via /coins/{id}Market Cap Rank
#13733
Circulating Supply
27.07
Total Supply
27.07
All-Time High
$175.23 · 2026-10-30
Categories
News & Insights
Also tokenized by
Gilead Sciences Tokenized Stock (Reality) is issued as 2 separate tokens across different issuers.
| Issuer | Token | Price | Market Cap | 24h Volume | Networks |
|---|---|---|---|---|---|
| xStocks | GILGILDX | — | — | — | — |
Alerts & digests
Coming soonReal-time price, NAV, mint, redemption alerts
Get pinged the moment RGILD crosses a price or spread threshold you set, or automated.
Breaking news alerts
Issuer, regulatory and depeg news for RGILD — the second it drops.
Daily summary
A once-a-day digest of RGILD's price, best yield and market moves in your inbox.
Analyze & download 24/7 history
Full round-the-clock historical data for RGILD — including off-market-hours — exportable to CSV.
Analyse with insight & news
AI-assisted analysis of RGILD paired with the latest issuer, regulatory and market news.